Insuman Comb 50 100units/ml suspension for injection 3ml cartridges has been discontinued with stocks being exhausted imminently, notified Department of Health
and Social Care (DHSC).
The department has issued a medicine supply notification for Insulin isophane biphasic human 50/50 (Insuman Comb 50) 100units/ml suspension for injection 3ml
cartridge.
"Humolog Mix 50 remains available, as do other biphasic insulin preparations, and the manufacturers can support a full uplift in supply," said DHSC.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I's newly launched online Medicines Supply Tool provides up to date information about medicine supply issues. The contents of these MSNs can now be
viewed on the Tool.
Side Wheel Attachment Hero Splendor:
Frame : 38 mm 16 Gauge CR Pipe With Powder Coated
Wheel Hub : Alloys Molded
2 Piece Tyre Size : 3.50 x 10 Inches
2 Piece Tube Size : 3.50 x 10 inches
2 Piece Shocks Up Heavy Duty
4 Piece ball baring
2 Piece pin bush
2 Piece mudguard chrome plated
2 Piece Disk with 4 Hole
Wheel Type: Alloy Wheel
Width: 40" to 48" inch
Carrying Capacity: 100 -150 kg
Assistive and small sit-down motor scooters provide important advantages to people with problems. A scooter is useful for persons without the stamina or arm/shoulder flexibility necessary to use a manual wheelchair. Also, swiveling the seat of an electric scooter is generally easier than moving the foot supports on most conventional wheelchairs. A mobility scooter is very helpful for persons with systemic or whole-body disabling conditions (coronary or lung issues, some forms of arthritis, obesity, etc.) who are still able to stand and walk a few steps, sit upright without torso support, and control the steering tiller.
Features:
Compact Design.
Ease of Maintenance.
Premium Product with best quality kit.
Quality Suspension.
Lifelong Durability.
Good Wheel Balancing.
Lifelong Durability.
As part of efforts to streamline spending and enhance resource allocation within the healthcare system, the NHS has chosen to cease providing the free
vaccinations for all, which were initially introduced in 2020. Approximately 12 million British citizens will not have access to free flu vaccinations and
Covid-19 boosters during the upcoming winter, according to NHS.
Furthermore, the NHS plans to defer flu vaccine distribution to October, aiming to heighten protection for those aged 65 and older and other eligible groups in
the high-risk winter months. However, this has stirred panic among pharmacies, given their advanced planning based on the initial start date of September 1 for
vaccinations.
On Tuesday (Aug. 8), the Joint Committee on Vaccination and Immunisation (JCVI) released NHS guidelines indicating that Covid-19 booster shots, starting from autumn,
will not be provided to individuals aged 50 to 64 who are in otherwise good health. Similar guidance had already been released for flu, rendering 12 million
middle-aged Britons ineligible for free jabs, JCVI said.
Prior to the pandemic, influenza vaccinations were available to healthy adults aged over 65, alongside children and younger adults with medical conditions. Amidst
the pandemic, the distribution of flu vaccinations was expanded to include individuals aged 50 to 64, in alignment with the criteria for Covid-19 boosters.
Businesses, including community pharmacies, that handle cash have been urged to prepare for the removal of £20 and £50 paper banknotes from circulation. The
paper notes of both denominations will no longer be legal tender from Friday 30 September.
Cash handling experts Volumatic reminded businesses to make sure that they deposit any paper notes at banks by this date, and ensure they would not be accepting any
further paper notes from customers from 1 October onwards.
"While businesses continue to face extra demands during the current cost-of living crisis, we've already seen evidence of an uplift in cash usage by consumers, who
are now using cash more to help them budget more effectively," Mike Severs, Sales and Marketing Director at Volumatic, said.
"With more consumers looking to spend their old paper notes before the end-of-September deadline, it's really important to remember to deposit any paper notes you
either already have within your business or receive throughout this month to your bank before the end of September."
All adults aged 50 years and above are eligible for free flu jabs in England under the autumn Covid-19 booster programme, the Department of Health and Social
Care (DHSC) has announced.
"The flu virus could also be highly infectious at this time of year, so I am also announcing that those eligible for a free flu vaccination this year will include
everyone aged 50 and over, primary school children and secondary school pupils in years 7, 8 and 9, as well as people in clinical risk groups, unpaid carers and
household contacts of those who are immunosuppressed," said new health secretary Steve Barclay.
Commenting on the DHSC's announcement, CCA chief executive Malcolm Harrison said: "We welcome the decision to accept the advice of the JCVI on who can have free
Covid-19 boosters and flu jabs this autumn. Community pharmacies have turbo-charged the Covid-19 vaccination programme over the past 18 months and last year we
witnessed the most successful community pharmacy flu campaign ever."
NHS England has agreed to offer an additional payment of £2.50 per jab if pharmacies would be willing to extend the duration of their COVID-19 vaccination
contract until 31st August 2024.
Pharmacies currently providing the autumn vaccination are asked to let their local commissioner know, by 22nd February 2024, if they can provide cover for a
potential Spring booster programme, if the Joint Committee on Vaccination and Immunisation (JCVI) advises in their guidance expected to be published soon.
NHS figures showed that more than 3,500 community pharmacies signed the contract to deliver COVID-19 vaccinations between 1 September 2023 and 31 March 2024, as
part of the autumn booster programme.
The health service is hoping that most of these pharmacies will be able to continue to support the Spring campaign, which will run from 1 April 2024 to 31st
August 2024, to help protect the nation's most vulnerable populations.
For the Spring campaign only, pharmacies would be offered an extra £2.50 per jab in addition to the existing item of service fee of £7.54, NHS England said.
Anadrol 50 is the highly potent anabolic steroid which appeared under the name of Androyd and Anadrol 50 in the 1960s. Also referred to as A50, the steroid brings about a significant weight gain. In US, it has become a very potent androgen used orally.
Rilutek 50Mg Tablet Indian Suppliers , This medication is employed to treat an explicit form of nerve unwellness known as amyotrophic lateral pathology (ALS, conjointly normally known as Lou Gehrig's disease). Riluzole helps to bog down the worsening of this unwellness and prolong survival. However, it's not a cure for ALS, and it doesn't reverse nerve injury or muscle weakness.
We are leading suppliers & exporters of "Rilutek 50Mg" in China, Russia, Hongkong, Bulgaria, Romania, India.We're largest suppliers of Aventis medicines & provide you the best price on Rilutek 50Mg.
The lowest price sellers, suppliers, distributors & Exporters from Delhi. For more info please contact us.
Rilutek 50Mg Tablet Indian Suppliers
Rilutek 50Mg Suppliers India
Rilutek 50Mg
Riluzole is believed to figure by protective the nerves within the brain and neural structure from an excessive amount of a natural substance known as salt which will be a part of the reason behind nerve injury.
RILUTEK (riluzole) may be a member of the benzothiazole category. The chemical designation for riluzole is 2-amino-6-(trifluoromethoxy) benzothiazole. Its chemical formula is C8H5F3N2OS, and its relative molecular mass is 234.2.
RILUTEK may be a white to slightly yellow powder that's terribly soluble in dimethylformamide, dimethylsulfoxide, and methanol; freely soluble in dichloromethane; meagrely soluble in zero.1 N HCl; and extremely slightly soluble in water and in zero.1 N NaOH.
Each film-coated Tablet for oral use contains 50 mg of riluzole and also the following inactive ingredients: anhydrous dibasic inorganic phosphate, mixture silica, croscarmellose atomic number 11, hypromellose, Mg stearate, crystalline polysaccharide, synthetic resin glycol, and titanium oxide.
If you're mistreatment the liquid type of this medication, gently shake the bottle for a minimum of thirty seconds before use. Rigorously live the dose employing a special mensuration device/spoon. Don't use a
Christie & Co, a specialist business property adviser, recently finalised the sale of two pharmacies-one located in Wales and the other in Hampshire.
Sylvia Williams Chemist, a well-performing community pharmacy located on the main high street of the Vale of Glamorgan market town of Cowbridge, has been sold
after an impressive 50 years of ownership.
Dispensing an average of 12,500 items monthly, the business has been owned by Kate Thomas and her family for nearly 50 years. It was put on the market to enable
her retirement and allow her to focus on other interests, the broker said.
The pharmacy has been purchased by Zaid Salih, making it his second pharmacy acquisition.
Jonathan Board, Director - Medical at Christie & Co, who handled the sale, said that Sylvia Williams Chemist attracted a wide range of buyers.
Once you have reached 50, you need to take extra care of your body and oral health. This is the time when people should be concerned about tooth loss, decay, oral infections, oral cancer, and gum diseases.
Solgar® is delighted to announce the launch of its newest innovation Solgar®Earth Source® Koji Iron 27mg. The new supplement is designed to support consumers'
everyday energy levels and uses an innovative koji fermentation process to transform mineral iron into an iron-rich fermented food which is high in bioavailability,easy to absorb and gentle on the stomach.
Available now in a 30-capsule bottle (Trade Price £6.50 - RRP £13.99/€14.50), each capsule will provide 27mg of naturally sourced koji food fermented iron. The
convenient one-a-day formulation offers a number of health benefits including:
Supporting energy and reducing tiredness and fatigue
Contributing to the formation of haemoglobin and red blood cells
Supporting cognition
Supporting immune defences
Minerals, including iron, support growth and development and ensure our bodies function optimally. Iron is present mostly in animal protein such as lean meats and
seafood, but also in nuts, tofu and white beans in smaller amounts. Iron supports the production of haemoglobin, the crimson pigment in red blood cells, that helps
carry oxygen around the body. It also helps energise the body, and athletes, for example, may need more iron to support oxygen transport to muscles so they can keep exercising.
Pharmacy chain Superdrug has introduced what it asserts to be the most affordable private flu vaccinations offered on the UK high street. The vaccinations
will be priced at £8.79 for 17.2 million members of its Ghada , and £16.99 for non-members. The 2023-24 vaccination service is set to become available across 150 of
its stores starting from early September.
Superdrug has taken this step in response to a change in NHS England's inclusion criteria, which has rendered the 12 million individuals aged 50-65 ineligible for
the NHS flu vaccination service, the company said. The company is anticipating heightened demand for private flu vaccinations due to the postponed commencement of
the NHS service and alterations in eligibility for free flu jabs.
"Our waiting list for private flu vaccination services has already exceeded last year's figures, indicating a heightened demand this year," said Ghada Beal,
Superdrug's Healthcare Director. "Providing this service at a more accessible price-point is significant, given the eligibility changes that will impact millions.
Our private flu vaccination services provide a convenient means for individuals to safeguard themselves against flu and its potential complications."
In May, the government's annual flu vaccination programme letter indicated that individuals aged 50 to 64 won't receive free flu vaccinations in the 2023/24
season. Moreover, the NHS plans to delay flu vaccine distribution to October, with the goal of enhancing protection for those aged 65 and older and other eligible
groups during the winter months.
NHS England has funded the Centre for Pharmacy Postgraduate Education (CPPE) to offer 80 free places in their Accuracy Checking Pharmacy Technician (ACPT)
programme.
Starting August 2024, up to 10 NHSE-funded places will be available each month on a first-come, first-served basis for pharmacy technicians working in community
pharmacy, NHS hospitals, and in health and justice.
The funding will continue until all 80 places are allocated or until March 2025.
CPPE has revealed that 50 per cent of the funding has been allocated for community pharmacy and 50 per cent for other sectors.
The ACPT programme is a 3-12 month course aimed at helping pharmacy technicians achieve various competencies, ensuring they can provide safe and effective patient
care.
Reclining wheelchair
Reclining wheelchairs are available in standard folding frames with extended head supports and seat widths up to 24" wide. The recline mechanism is attendant operated with levers much like a bicycle brake lever. The levers operate hydraulic (pump) mechanisms for a smooth adjustment. Using this reclining mechanism, the chair back can easily and frequently be positioned to any angle.
Recliner wheelchair is low profile allowing you to comfortably fit under tables and desks. You can also enjoy numerous activities with increased comfort such as stretching, napping and watching television. The ability to recline also improves circulation and the ability for sore spots to heal.
We offer best quality Reclining Wheelchair which are suitable for indoor as well as outdoor purposes. Reclining Wheelchair are using high quality material to ensure high strength and durability. Our range of wheelchairs are available in foldable frames and are capable for 100 kgs.
Features:
Foldable frame.
Foldable armrest.
Foldable /detachable footrest.
Dual brake system.
Seat - fabric seat with foam.
Backrest - fabric backrest with foam.
Total weight- 26kgs.
Front wheels -8" solid wheels, rear wheels 24" solid.
Self propelling/ attendant type.
Reclining type backrest use of lever.
Detachable / adjustable headrest.
Benefits of Reclining Wheelchairs
Comfort - Recliner wheelchairs greatly improve the comfort factor of being in a wheelchair. Many scenarios such as lying down, reclining under desks, and eating with food trays are much easier.
Pressure Sores - The ability to recline helps distribute body weight and reduce pressure sores.
Transfers - Transferring from a reclining wheelchair to a bed is much easier than the standard wheelchair. The wheelchair can be adjusted to the same elevation as the bed; the user only needs to slide from the chair to the bed.
wheelchair category (standard, transport, power, etc.) could be classified as a reclining wheelchairs, since the product class is built around one key feature: the capability to adjust the backrest and/or footrest into a reclined position. This feature is especially important to users who find it difficult or impossible to sit in a fully upright position, and users who sleep in their chairs frequently. For those that are looking for a more portable chair, however, products from this category may not be a great fit. When compared with a similar, non-reclining chair, a reclining wheelchair tends to weigh more and - unlike other manual models - manual wheelchairs that recline typically aren't foldable.
Some people use special wheelchairs to distribute pressure and thus reduce the risk of skin sores. These chairs also increase comfort and sitting tolerance. One type of chair, called "tilt in space," changes a person's orientation while maintaining fixed hip, knee, and ankle angles. The whole seat, in effect, tilts. The other chair option is called a recline system, which basically changes the seat-to-back angle, flattening out the back of the chair and in some cases raising the legs to form a flat surface.
Different Types Of Reclining Wheelchairs:
Reclining Wheelchair 902 GC
Reclining Wheelchair 609 GC
Karma Aurora 4 Reclining Wheelchair
Karma Reclining Wheelchair KM 5000
Karma VIP 515 Wheelchair
Reclining Wheelchair 902 GC:
Reclining Wheelchair 902 GC is one of the basic models of a Reclining Wheelchair which helps transfer to bed to wheelchair easily and comes with head and neck support and Calf support for added comfort.
Reclining Wheelchair 902 GC Features:
The chair boast of movable armrest and elevating footrest.
A well padded thigh support helps the user thigh's during reclining.
The front and the rear wheels are designed and placed in such a way so as to support the users weight during reclining.
The Pneumatic rear wheels help the movement
50% off second pair of eyeglasses when using insurance on your pair or when purchasing a year supply of contacts. Some restrictions may apply. Offer expires March 31, 2015. Ask for any details Email us: ovstaff@overlandoptical.com & Visit Now http://www.overlandoptical.com.
Consumer goods giant Unilever signalled on Monday (January 17) it would pursue a deal for GlaxoSmithKline's consumer healthcare business, calling it a "strong strategic fit" after its £50 billion offer was refused.
GSK confirmed on Saturday that it had rejected three approaches from the Dove-soap maker, adding it intended to stick to its own plan to spin off the business as a separate company later this year.
"GSK Consumer Healthcare would be a strong strategic fit," Unilever said in a statement as it unveiled a strategy update in the wake of the weekend's takeover news.
Unilever said it was "committed to accelerating the company's growth and repositioning the portfolio into higher growth categories.
"As a result of the reporting of Unilever's interest in GSK Consumer Healthcare, we are today bringing forward a planned update, setting out the strategic direction that the company is pursuing," Unilever said.
NHS England delivered 358 million general practice (GP) appointments, including Covid-19 vaccinations, in the 12 months to October 2023, an increase
of 50.9 million compared to October 2019.
This equals to 44 more appointments per practice per working day, with over 70 per cent of these taking place within two weeks of booking, data published by
NHSE on Thursday (30 November) showed.
Health Minister, Andrea Leadsom, thanked GPs and primary care teams across the country for making it possible to deliver around 32,500 more appointments
every day, which clearly demonstrate that "more people are getting the care they need, when they need it."
"While this is positive news, we know that there is more to do to make it easier and quicker for patients to contact their general practice and continue to
focus on delivering the Primary Care Recovery Plan," she added.
The Primary Care Recovery Plan published earlier this year is focused on improving access to primary care. It provided GPs in England with £240 million to
support them to embrace the latest technology to tackle the 8am rush, and handle more appointments.
As of August 2023, more than 1,000 general practices had signed up to digital upgrades to make booking GP appointments easier.
The Pharmacy First service, set for launch in England at the end of January, is expected to help reduce some of the pressure on the National Health Service (NHS).
But the question is - Are pharmacists ready to take the extra workload amidst many issues community pharmacies are currently facing?
Nearly 50 per cent of pharmacy workers surveyed by ITV News said they do not feel confident they can provide the new services.
Pharmacy leaders told the British news channel that the industry is already in crisis, and they are facing a "potentially fatal cocktail" of rising prices, major
supply problems and a lack of funding.
Campaigners have submitted an open letter to the Department of Health and Social Care (DHSC), urging the Minister for Primary Care and Public Health to
freeze prescription charges to keep people with long-term conditions alive and well.
The campaign is led by the Prescription Charges Coalition, which represents over 50 organisations, including Royal Pharmaceutical Society (RPS) and Pharmacists'
Defence Association (PDA).
Currently, the prescription charge is £9.65 per item, and campaigners have asked the government to freeze it for 2024 and 2025 as people living with long-term
health conditions in England are "being forced to choose between heating, eating, and taking their vital medication on a daily basis."
In 2023, a study conducted by the Prescription Charges Coalition revealed that almost 10 per cent of survey participants had skipped medication in the previous
year due to the cost of prescriptions. This led to increased physical and mental health problems, as well as impacted the time they took off work.
Laura Cockram, Chair of the Prescription Charges Coalition and Head of Campaigns at Parkinson's UK, expressed deep concern that a further rise in the charge this
year will lead to people skipping or not taking the full dose of their medication, which will affect their health and put more pressure on the already under
pressure NHS.